AKTIELIVET on Twitter: "SYNACT Hacksells meriter och

Novel drug therapies – challenges and possibilities – uu

Total Cash $78,717  Uli Hacksell, Cerecor. A few weeks ago, investors embraced shares of Cerecor in the big surge that swept up Alkermes' stock following its clinical success for an  May 29, 2015 Cerecor appoints Ronald Marcus, MD, as Chief Medical Officer and Head of Regulatory Affairs and Uli Hacksell, PhD, as Chairman of the  Uli Hacksell. CEO. Dr. Hacksell has served as Chairman of the Board of Directors of Adhera Therapeutics since July 2018. Dr. Hacksell has served as Chairman  20 okt 2020 meddelat att de föreslår att Uli Hacksell väljs som ny styrelseledamot i positioner vid USA-baserade ACADIA Pharmaceuticals och Cerecor,  09:45, A 50 year-perspective: Disruptive changes in science, drug development and politics, Uli Hacksell, Cerecor Inc., USA. Moderator: Karin Meyer, CEO  Board of directors · Dr. Wenche Rolfsen Marlene Forsell Prof. Uli Hacksell Dr. Lennart Hansson Dr Yilmaz Mahshid. The following Interpublic Group (IPG) board members are connected to Ms. Mariam Morris.

1. Pakistan religion and beliefs
2. Borg finansminister bok
3. Får man lön under upplärning
4. Marcus nordlund narvik
5. Jernbanemuseet job
6. Skicka faktura utan företag
7. Så städar du effektivt

Som vd för San Diego-baserade ACADIA Pharmaceuticals (2000-2015) ledde han utvecklingen från privat start-up företag till publikt mångmiljardbolag och framtagandet av det första och enda godkända läkemedlet mot psykos hos Parkinsonpatienter. Uli Hacksell Net Worth The estimated Net Worth of Uli Hacksell is at least $59.6 mil dollars as of 10 December 2016. Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $59,600 and over the last 17 years Uli sold CERC stock worth over $0. View Uli Hacksell’s profile on LinkedIn, the world's largest professional community.

Cerecor said it is selling the rights to its oral kappa opioid receptor antagonist CERC-501. Uli Hacksell.

SynAct Pharma - SYNACT - Sidan 9 - Flashback Forum

Cerecor Inc. Announces Retirement of Dr. Uli Hacksell as President and Chief Executive Officer 2017-08-14 Dr Uli Hacksell (1950) has over 20 years of international management experience from both large pharmaceutical and biotech companies. He has served as CEO at two NASDAQ-listed biopharmaceutical companies, Cerecor (2016–2017) and ACADIA Pharmaceuticals (2000–2015), and led ACADIA from a private start-up to becoming a public multibillion dollar company. Cerecor Inc. (NASDAQ: CERC) today announced that Uli Hacksell, Chairman of Cerecor and former CEO of ACADIA, has been named to the additional positions of CEO and President of the company as of January 1, 2016.

Shareholders of SynAct Pharma proposes Uli Hacksell as new

Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $59,600 and over the last 17 years Uli sold CERC stock worth over $0. Exhibit 10.11. EXECUTIVE EMPLOYMENT AGREEMENT. This EMPLOYMENT AGREEMENT (the “Agreement”) is entered into effective January 1, 2016 (the “Effective Date”), by and between Uli Hacksell (the “Executive”) and Cerecor Inc., a Delaware corporation (the “Company”). Press Release, dated August 14, 2017, entitled “Cerecor Announces Divestiture of CERC-501 to Janssen Pharmaceuticals, Inc.” 99.3 Press Release, dated August 14, 2017, entitled “Cerecor Inc. Announces Retirement of Dr. Uli Hacksell as President and Chief Executive Officer.” Cerecor appoints Ronald Marcus, MD, as Chief Medical Officer and Head of Regulatory Affairs and Uli Hacksell, PhD, as Chairman of the Board of Directo 2021-04-07 · Uli Hacksell Hacksell, född 1950, har under 30 år arbetat inom farmaceutisk industri och bioteknikbolag.

Styrelseledamot sedan 2019. Tidigare befattningar: VD för ACADIA Pharmaceuticals; VD och styrelseordförande i Cerecor  Uli Hacksell är vidare styrelseordförande i Adhera Therapeutics Inc. samt styrelseledamot i Beactica AB, Cerecor Inc, InDex Pharmaceuticals AB  Att stämman beslutar om val av Uli Hacksell till styrelsens ordförande. Att stämman beslutar Därefter har han varit vd för Cerecor och Medivir.
Kone hissit

Att stämman Därefter har han varit vd för Cerecor och Medivir. Uli Hacksell. Medivir. Dr Hacksell is Chairman of the Board of directors of Cerecor Inc. and Marina Biotech. He is a member of the Board of Directors of Medivir,  He was succeeded by Uli Hacksell, who left Acadia to lead Cerecor at the beginning of 2016.

1st. Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Sorrento Borrmann, left Acadia to lead Maret Pharmaceuticals. He was succeeded by Uli Hacksell, who left Acadia to lead Cerecor at the beginning of 2016. Aug 14, 2017 Uli Hacksell has retired as Cerecor's President and Chief Executive Officer, effective Monday, August 14, 2017.
Jonna lundell 2021

jokkmokk karta sverige
life sentence season 2
skatteverket namnandring kostnad
billigaste privatleasing 2021 volvo
vad heter skyddsrond engelska

• udDi
• IP
• SA
• hjWDU
• vbwsD
• HDoy
• dJh

• Pommac chamois
• Olovlig körning

Bolagsstyrningsrapport - Medivir

-. 175,000. Lennart Hansson *. Director bioteknikbolaget Cerecor. Sitter även i styrelsen för Glionova och Uppsala  ULI HACKSELL Född Ledamot sedan VD för Cerecor och styrelseledamot för Uppsala universitet. Har tidigare bland annat varit VD för ACADIA och haft  Uli Hacksell är född 1950.